Bladder cancer patient Margo Wickersham describes her arduous journey with a very serious type of bladder cancer, how she coped during medical distancing during COVID, and what BCAN's support meant to her.

Dr. Matt Galsky discusses how and why chemotherapy works for bladder cancer in the neoadjuvant and adjuvant settings.

Hear BCAN Co-Founder Diane Zipursky Quale, Mayo Clinic Arizona medical oncologist Parminder Singh, MD, and St. John’s Cancer Center urologist Jennifer Linehan, MD, and urologist Donald Lamm, MD, FACS from BCG Oncology discuss recent and upcoming bladder cancer research advances.

Have you ever heard about bladder cancer? Watch our short video animation to learn more about signs & symptoms of bladder cancer to look out for!

During World Bladder Cancer Awareness Month 2021 throughout May, ask "Have you ever heard about bladder cancer?" to others and share this video. Help us raise awareness. Every action matters, if we do it together!

The New Immuno-Oncology Era in Early-Stage Bladder Cancer

Co-Chairs, Matthew D. Galsky, MD, and Neal D. Shore, MD, FACS, discuss bladder cancer in this CME/MOC activity titled “The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Modern Urology Practice.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/FPT865. CME/MOC credit will be available until April 10, 2024.

Dr. Ashish Kamat, Professor of Urologic Oncology and Director of Bladder Cancer Research at MD Anderson Cancer Center, and Dr. Arlene Siefker-Radtke, Professor of Urologic Oncology and Director of Bladder Cancer Research at MD Anderson Cancer Center, share information on advanced/metastatic bladder cancer.

Trans-urethral resection of bladder tumor (TURBT) is a minimally invasive surgical procedure used to remove abnormal growths in the bladder through the urethra, promoting diagnosis, treatment, and preservation of bladder function.